Assessing the added value of group B Streptococcus maternal immunisation in preventing maternal infection and fetal harm: population surveillance study.
Adolescent
Adult
England
/ epidemiology
Female
Hospitalization
Humans
Infant, Newborn
Infant, Newborn, Diseases
/ epidemiology
Medical Records
Population Surveillance
Pregnancy
Pregnancy Complications, Infectious
/ epidemiology
Prenatal Care
State Medicine
Streptococcal Infections
/ epidemiology
Streptococcus agalactiae
/ immunology
Vaccination
Young Adult
Streptococcus agalactiae
England
ethnic groups
infectious
population surveillance
pregnancy complications
surgical wound infection
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
09
07
2021
received:
04
02
2021
accepted:
20
07
2021
pubmed:
30
7
2021
medline:
27
1
2022
entrez:
29
7
2021
Statut:
ppublish
Résumé
To assess the incidence of maternal group B Streptococcus (GBS) infection in England. Population surveillance augmented through data linkage. England. All pregnant women accessing the National Health Service (NHS) in England. Invasive GBS (iGBS) infections during pregnancy or within 6 weeks of childbirth were identified by linking Public Health England (PHE) national microbiology surveillance data for 2014 to NHS hospital admission records. Capsular serotypes of GBS were determined by reference laboratory typing of clinical isolates from women aged 15-44 years. Post-caesarean section surgical site infection (SSI) caused by GBS was identified in 21 hospitals participating in PHE SSI surveillance (2009-2015). iGBS rate per 1000 maternities; risk of GBS SSI per 1000 caesarean sections. Of 1601 patients diagnosed with iGBS infections in England in 2014, 185 (12%) were identified as maternal infections, a rate of 0.29 (95% CI 0.25-0.33) per 1000 maternities and representing 83% of all iGBS cases in women aged 18-44 years. Seven (3.8%) were associated with miscarriage. Fetal outcome identified excess rates of stillbirth (3.4 versus 0.5%) and extreme prematurity (<28 weeks of gestation, 3.7 versus 0.5%) compared with national averages (P < 0.001). Caesarean section surveillance in 27 860 women (21 hospitals) identified 47 cases of GBS SSI, with an estimated 4.24 (3.51-5.07) per 1000 caesarean sections, a median time-to-onset of 10 days (IQR 7-13 days) and ten infections that required readmission. Capsular serotype analysis identified a diverse array of strains with serotype III as the most common (43%). Our assessment of maternal GBS infection in England indicates the potential additional benefit of GBS vaccination in preventing adverse maternal and fetal outcomes.
Identifiants
pubmed: 34324252
doi: 10.1111/1471-0528.16852
pmc: PMC9291181
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-240Subventions
Organisme : PHE
Informations de copyright
© 2021 Crown copyright. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd. This article is published with the permission of the Controller of HMSO and the Queen's Printer for Scotland.
Références
Infect Drug Resist. 2020 Apr 29;13:1263-1272
pubmed: 32425562
Pediatr Neonatol. 2019 Oct;60(5):487-495
pubmed: 31445795
Int J Infect Dis. 2019 Jun;83:116-129
pubmed: 31028879
PLoS Med. 2017 Nov 14;14(11):e1002425
pubmed: 29136007
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S112-S124
pubmed: 29117328
BMJ Open. 2020 Jul 20;10(7):e036919
pubmed: 32690746
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):107-13
pubmed: 22907333
J Clin Microbiol. 2011 Apr;49(4):1475-82
pubmed: 21325542
Clin Infect Dis. 2013 Sep;57(5):682-8
pubmed: 23845950
BJOG. 2012 Oct;119(11):1324-33
pubmed: 22857605
BMJ Open. 2015 Oct 08;5(10):e007976
pubmed: 26450426
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S125-S132
pubmed: 29117322
J Exp Med. 1935 Feb 28;61(3):335-49
pubmed: 19870362
BJOG. 2019 Oct;126(11):1347-1353
pubmed: 30734508
BJOG. 2022 Jan;129(2):233-240
pubmed: 34324252
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S100-S111
pubmed: 29117327
J Exp Med. 1933 Mar 31;57(4):571-95
pubmed: 19870148
Clin Infect Dis. 2011 Jul 15;53(2):114-23
pubmed: 21690617